01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

More documents

Recommendations

Info

hepatocytes: expression of the LDL receptor. Hum Gene Ther 6, 21-30. Pages J-C, Loux N, Bellusci S, Farge D, Bennoun M, Vons C, Jouanneau J, Franco D, Briand P, Weber A (1996a) Hepatocyte growth factor expressed by a retrovirusproducing cell line enhances retroviral transduction of primary hepatocytes: implications for in vivo gene transfer. Biochem Biophys Res Commun 222, 726-731. Pages JC, Andreoletti M, Loux N, Vons C, Mahieu D, Bargy F, Chapman J, Briand P, Franco D, Weber A (1996b) Towards gene therapy in familial hypercholesterolemia (in french) C R Seances Soc Biol Fil 190, 53-65. Paik SY, Banerjea A, Chen CJ, Ye Z, Harmison GG, Schubert M (1997) Defective HIV-1 provirus encoding a multitargetribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis. Hum Gene Ther 8, 1115-1124. Paleyanda RK, Velander WH, Lee TK, Scandella DH, Gwazdauskas FC, Knight JW, Hoyer LW, Drohan WN, and Lubon H (1997) Transgenic pigs produce functional human factor VIII in milk. Nature Biotech 15, 971-975. Palmer TD, Hock RA, Osborne WRA, Miller AD (1987) Efficient retrovirus-mediated transfer and expression of a human adenosine deamnase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci USA 84, 1055-1059. Palmer TD, Rosman GJ, Osborne WRA, Miller AD (1991) Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 88, 1330-1334. Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso C-L, Dekernion JB, and Belldegrun AS (1995) Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum Gene Ther 6, 1417-1426. Papathanasiou MA, Kerr NCK, Robbins JH, McBride OW, Alamo Jr I, barrett SF, Hickson ID, Fornace Jr AJ (1991) Induction by ionizing radiation of the gadd45 gene in cultured human cells: Lack of mediation by protein kinase C. Mol Cell Biol 11, 1009-1016. Park K, Choe J, Osifchin NE, Templeton DJ, Robbins PD, Kim SJ (1994) The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product. J Biol Chem 269, 6083-6088. Parker SE, Vahlsing HL, Serfilippi LM, Franklin CL, Doh SG, Gromkowski SH, Lew D, Manthorpe M, Norman J (1995) Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates. Hum Gene Ther 6, 575-590. Parker WB, King SA, Allan PW, Bennett LLJr, Secrist JAIII, Montgomery JA, Gilbert KS, Waud WR, Wells AH, Gillespie GY, and Sorscher EJ (1997) In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. Hum Gene Ther 8, 1637-1644. Parkman R (1986) The application of bone marrow transplantation to the treatment of genetic diseases. Science 232, 1373-1378. Boulikas: An overview on gene therapy 152 Patterson BC and Sang QA (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272, 28823-28825. Pennacchio LA et al (1996) Mutations in the gene encoding cystatin B in progressive myoclonous epilepsy (EPM1). Science 271, 1731-1734. Perrouault L, Asseline U, Rivalle C, Thuong NT, Bisagni E, Giovannangeli C, Le Doan T, Hélène C (1990) Sequencespecific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides. Nature 344, 358-360. Perry ME, Piette J, Zawadzki JA, Harvey D and Levine AJ (1993) The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci USA 90, 11623-11627. Peters C, Rommerskirch W, Modaressi S, von Figura K (1991) Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviralvector-mediated gene transfer. Biochem J 276,499-504. Peters K-R, Carley WW and Palade GE (1985) Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure. J Cell Biol 101, 2233-2238. Peterson KR, Clegg CH, Li Q, Stamatoyannopoulos G (1997) Production of transgenic mice with yeast artificial chromosomes. Trends Genet 13, 61-66. Phillips MI (1997) Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29, 177-187. Phillips MI, Mohuczy-Dominiak D, Coffey M, Galli SM, Kimura B, Wu P, Zelles (1997) Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adenoassociated viral vector delivery of AT1-R mRNA antisense. Hypertension 29, 374-380. Pietenpol JA, Holt JT, Stein RW, Moses HL (1990) Transforming growth factor β 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87, 3758-3762. Plank C, Mechtler K, Szoka FC Jr, Wagner E (1996) Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 7, 1437-1446. Plate KH, Breier G, Weich HA, and Risau W (1992) Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359, 845-848. Pochon NA-M, Heyd B, Déglon N, Joseph J-M, Zurn AD, Baetge EE, Hammang JP, Goddard M, Lysaght M, Kaplan F, Kato AC, Schluep M, Hirt L, Regli F, Porchet F, and de Tribolet N (1996) Clinical Protocol: Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymerencapsulated xenogenic cell line engineered to secrete hCNTF. Hum Gene Ther 7, 851-860. Podda S, Ward M, Himelstein A, Richardson C, De La Flor- Weiss E, Smith L, Gottesman M, Pastan I, Bank A (1992) Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89, 9676-9680.
Polyak K, Xia Y, Zweier JL, Kinzler KW, and Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389, 300-305. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, and Duvoisin RC (1996) Mapping of a gene for Parkinson’s Disease to chromosome 4q21-q23. Science 274, 1197-1199. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. Pombo A, Ferreira J, Bridge E, and Carmo-Fonseca M (1994) Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J. 13, 5075-5085. Ponnazhagan S, Erikson D, Kearns WG, Zhou SZ, Nahreini P, Wang XS, Srivastava A (1997a) Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther 8, 275-284. Ponnazhagan S, Yoder MC, Srivastava A (1997b) Adenoassociated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol 71, 3098-3104. Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ, Carothers AD, Wallace WA, Moralee S, Hoenes C, Kallmeyer G, Michaelis U, Naujoks K, Ho LP, Samways JM, Imrie M, Greening AP, Innes JA (1997) Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4, 210-218. Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245, 186-188. Praseuth D, Perrouault L, Le Doan T, Chassignol M, Thuong N, Hélène C (1988) Sequence-specific binding and photocrosslinking of α and β oligodeoxynucleotides to the major groove of DNA via triple-helix formation. Proc Natl Acad Sci USA 85, 1349-1353. Prehn JH, Bindokas VP, Jordan J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Thompson CB, Krajewski S, Reed JC, Miller RJ (1996) Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49, 319-328. Prives C (1994) How loops, B sheets, and helices help us to understand p53. Cell 78: 543-546. Prives C and Manfredi JJ (1993) The p53 tumor suppressor protein: meeting review. Genes Dev 7, 529-534. Pruijn, G.J.M., van Driel, W. and van der Vliet, P.C. (1986) Nuclear factor III, a novel sequence-specific DNA-binding protein from HeLa cells stimulating adenovirus DNA replication. Nature 322, 656-659. Gene Therapy and Molecular Biology Vol 1, page 153 153 Pulaski BA, Yen K-Y, Shastri N, Maltby KM, Penney DP, Lord EM, and Frelinger JG (1996) Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci USA 93, 3669-3674. Putzer BM, Hitt M, Muller WJ, Emtage P, Gauldie J, Graham FL (1997) Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc Natl Acad Sci USA 94, 10889-10894. Qin L, Ding Y, Bromberg JS (1996) Gene transfer of transforming growth factor-β1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 7, 1981-1988. Qin XQ, Livingston DM, Kaelin WG Jr, Adams PD (1994) Deregulated transcription factor E2F-1 expression leads to Sphase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91, 10918-10922. Quesada P (1998) Poly (ADP-ribosyl)ation as one of the molecular events that accompany mammalian spermatogenesis. Gene Ther Mol Biol 1, 681-699. Rade JJ, Schulick AH, Virmani R, Dichek DA (1996) Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med 2, 293-298. Rader DJ (1997) Gene therapy for atherosclerosis. Int J Clin Lab Res 27, 35-43. Raffo AJ, Perlman H, Chen M-W, Day ML, Streitman JS, Buttyan R (1995) Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55, 4438-4445. Rajagopal P and Feigon J (1989) Triple-strand formation in the homopurine:homopyrimidine DNA oligonucleotides d(G- A)4 and d(T-C)4. Nature 339, 637-640. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS (1995) Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res 55, 4575- 4580. Rakhmilevich AL, Janssen K, Turner J, Culp J, Yang NS (1997) Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12. Hum Gene Ther 8, 1303-1311. Ramesh N, Shin YK, Lau S, Osborne WRA (1995) High-level expression from a cytomegalovirus promoter in macrophage cells. Hum Gene Ther 6, 1323-1327. Ramesh R, Marrogi AJ and Freeman SM (1998) Tumor killing using the HSV-tk suicide gene. Gene Ther Mol Biol 1, 253- 263. Ramezani A, Ding SF, Joshi S (1997) Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes. Gene Ther 4, 861-867. Rapaport D, Ovadia M, Shai Y (1995) A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging
Page 1 and 2:
Gene Ther Mol Biol Vol 1, 1-172. Ma
Page 3 and 4:
I. Introduction Monumental progress
Page 5 and 6:
The use of retroviral vectors in hu
Page 7 and 8:
displaying the cleavable EGF domain
Page 9 and 10:
molecules in the nucleus (Lowe and
Page 11 and 12:
sensitive mutations which allow pro
Page 13 and 14:
processed as described in panel A s
Page 15 and 16:
On the contrary, the payload capaci
Page 17 and 18:
in K562 human erythroleukemia cells
Page 19 and 20:
defective HSV virus (DeLuca and Sch
Page 21 and 22:
complex into the cytosol from the e
Page 23 and 24:
Gene Therapy and Molecular Biology
Page 25 and 26:
delivered by Sendai virus-liposome
Page 27 and 28:
plasmids with the cell surface, tra
Page 29 and 30:
infected by adenovirus alone; infec
Page 31 and 32:
Page 33 and 34:
B. Transcription factor binding sit
Page 35 and 36:
A closely related family of ubiquit
Page 37 and 38:
cells. I-CreI is a member of this c
Page 39 and 40:
Page 41 and 42:
C. Considerations of chromatin stru
Page 43 and 44:
Page 45 and 46:
A. The molecular basis of cancer im
Page 47 and 48:
fragments, or heat shock proteins c
Page 49 and 50:
ecombinant vaccinia virus expressin
Page 51 and 52:
HIV-1 envelope DNA construct develo
Page 53 and 54:
inding sites A GYYY oriented in opp
Page 55 and 56:
Page 57 and 58:
Prives, 1994). Whereas the wild-typ
Page 59 and 60:
mutant p53 (mutations on p53 are wi
Page 61 and 62:
master regulator of the cell cycle
Page 63 and 64:
Work from several groups has shown
Page 65 and 66:
chromatin condensation, drop in pH,
Page 67 and 68:
Figure 23. A pathway leading to the
Page 69 and 70:
Excessive necrotic death in cells o
Page 71 and 72:
implantation, and similar processes
Page 73 and 74:
normal cells in the surroundings. T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
A bicistronic retroviral vector (Ha
Page 81 and 82:
C. Antisense ras gene transfer for
Page 83 and 84:
equal to 6.0 showed S1 hyperreactiv
Page 85 and 86:
protein (e.g. Smith et al, 1995; Fo
Page 87 and 88:
transduced primary mouse fibroblast
Page 89 and 90:
IL-1 - receptor antagonist protein
Page 91 and 92:
p53 lung cancer retroviru s MHC cla
Page 93 and 94:
Page 95 and 96:
designed by immunization with porti
Page 97 and 98:
Isolation of an RNA aptamer that ca
Page 99 and 100:
induction of human apoE in neonate
Page 101 and 102: atrium in heart, endothelial cells
Page 103 and 104: which eliminated tumors in small an
Page 105 and 106: C. Transfer of other genes against
Page 107 and 108: Gene Therapy and Molecular Biology
Page 109 and 110: significant reduction in neointima
Page 111 and 112: (Prehn et al, 1996); this implies a
Page 113 and 114: B. Approaches to gene therapy of RA
Page 115 and 116: of human immunoglobulin and antigen
Page 117 and 118: A. Etiology and mechanisms of destr
Page 121 and 122: However, CsA also inhibits the acti
Page 123 and 124: The peptide kinin, after binding to
Page 125 and 126: intake when administered to adrenal
Page 127 and 128: Introgen Therapeutics (Austin and H
Page 129 and 130: When a subfragment of only 513 bp o
Page 131 and 132: Armentano D, Zabner J, Sacks C, Soo
Page 133 and 134: Brady HJM, Miles CG, Pennington DJ,
Page 135 and 136: Chen J, Stickles RJ, Daichendt KA (
Page 137 and 138: Day ML, Wu S, Basler JW (1993) Pros
Page 139 and 140: Farmer G, Bargonetti J, Zhu H, Frie
Page 141 and 142: Giovannangeli C, Perrouault L, Escu
Page 143 and 144: the neoplastic phenotype by replace
Page 145 and 146: integrate in a site-specific fashio
Page 147 and 148: Li R, Waga S, Hannon GJ, Beach D, S
Page 149 and 150: adiation-induced apoptosis in the g
Page 151: Nakaya T, Iwai S, Fujinaga K, Sato
Page 155 and 156: macrophages from simian immunodefic
Page 157 and 158: intimal hyperplasia in a rat caroti
Page 159 and 160: Trono D, Feinberg MB, Baltimore D (
Page 161 and 162: Wattiaux R, Jadot M, Warnier-Pirott
Page 163 and 164: similar to mammalian interleukin-1
Page 167 and 168: 24. Gene Marking /Infectious Diseas
Page 169 and 170: Drug 50. Gene Therapy /Phase I /Can
Page 171 and 172: 76. Gene Therapy /Phase I /Cancer /
Page 173 and 174: 99. Gene Therapy /Phase II /Cancer
Page 175 and 176: 120. Gene Therapy /Phase I /Monogen
Page 179 and 180: cancer not specified) /Immunotherap
show all

01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Create successful ePaper yourself

Delete template?

Save as template?